MRTX
Mirati Therapeutics, Inc.

Market cap $690.94M
Enterprise value $550.48M
Employees 52
Revenue N/A
EBITDA -$70.5M
Income -$72.3M
EPS -3.07
P/E N/A
Forward P/E -10.49
EV/EBITDA -7.81
PEG N/A
Earnings date 2017-03-07
Volume 955k / 459k
Relative vol. 2.08 ×
Ret. on assets -54.79%
Return on equity -108.14%
Beta 1.74
Mean Recomm. 1.70
IPO year 2013
Country United States
RSI 80.45
Range $22.65 – $25.20
52 weeks $2.70 – $25.20
SMA 50 $18 -27.74%
SMA 200 $11 -54.86%
1 year target $18 -25.54%

Intraday

5 days

1 month

3 months

6 months

1 year

5 years

10 years

All time

Messenger